Sports Medicine Market by Product (Body Reconstruction & Repair, Body Support & Recovery Products, Body Monitoring and Evaluation Devices and Accessories), Application (Knee Injuries, Shoulder Injuries, Ankle & Foot Injuries, Back & Spine Injuries, Elbow & Wrist Injuries, Hip Injuries, & Other Injuries): Global Opportunity Analysis and Industry Forecast, 2021-2030
The sports medicine market was valued at $8520 million in 2020, and is projected to reach $12862 million by 2030, registering a CAGR of 5.1% from 2021 to 2030.
Sports medicine is an area of medical practice concerned with the treatment of injuries resulting from athletic activities. It is a study that deals with improving physical fitness and preventing sports-associated injuries. Major objective of sports medicine is to enhance the athletic performance and prevent future injuries. Sports medicine aids in the treatment of injuries resulting from physical activity. In addition, sports medicine assists to maximize function and minimize the disability of patients. Key factors that drive the market growth include rise in incidences of injuries associated with sports, increase in adoption of sports activities by people, and growth in demand for minimally invasive treatment methods.
Thus, rise in incidences of sports injuries worldwide propels demand for the market growth. Moreover, government initiatives for the sports industry are continuously liable for expansion of the market. However, high cost of products may hinder expansion of the medicine market.
Rise in adoption of extreme sports activities, rise in incidences of sports related injuries, growth in awareness among individuals regarding fitness and sports, and rapid advancements in sports medicine are some factors expected to drive the sports medicine market growth.
The COVID-19 impact on sports medicine market is overall negative. This is attributed to the fact that the non-COVID-19 related healthcare facilities remained non-functional during the pandemic initially in 2020. Furthermore, factors such as decline* in the number of sport events and activities organized across the globe led to decrease in incidences of sports injury, which propels demand for sport medicines in a negative manner. In addition, the sports medicine market experienced disruptions in supply chain. This also contributed toward negative impact in growth of the sports medicine market in the year 2020. However, as the lockdown restrictions were relaxed in 2021, the demand for sports medicine exhibited a steady rise and recovery from COVID-19 impact.
The global sports medicine market is segmented on the basis of product, application, and region. By product, it is classified into body reconstruction & repair products, body support & recovery products, body monitoring & evaluation, and accessories. Body reconstruction & repair products are sub-segmented into implants, arthroscopy devices, fracture and ligament repair devices, prosthetic devices, and orthobiologics. Further, body support & recovery products are sub-segmented into thermal therapy products, brace and support devices, and compression clothing. Body monitoring and evaluation is sub-segmented into cardiac monitoring & evaluation, respiratory monitoring & evaluation, hemodynamic monitoring & evaluation, muscoskeletal monitoring & evaluation, and other monitoring & evaluation.
By application, it is divided into knee injuries, shoulder injuries, ankle & foot injuries, elbow & wrist injuries, hip & groin injuries, back & spine injuries, and other injuries.
Region wise, it is segmented into North America, Asia-Pacific, Europe, and LAMEA.
Key Benefits for Stakeholders
The study provides an in-depth analysis, current trends, and future estimations of the global market to elucidate the imminent investment pockets.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
A quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of key segments of the industry is provided to understand the type of products and indications used globally.
Key market players and their strategies are analyzed to understand the competitive outlook of the market.
Key Segments:
By Product
Body Reconstruction and Repair
Implants
Arthroscopy Devices
Fracture and Ligament Repair Devices
Prosthetic Devices
Orthobiologics
Body Support and Recovery
Thermal Therapy Products
Brace and Support Devices
Compression Clothing
Monitoring Devices
Others
Body Monitoring and Evaluation Devices
Cardiac monitoring and evaluation devices
Respiratory monitoring and evaluation devices
Hemodynamic monitoring and evaluation devices
Muscoskeletal monitoring and evaluation devices
Other monitoring and evaluation devices
Accessories
By Application
Knee Injuries
Shoulder Injuries
Ankle and Foot Injuries
Back and Spine Injuries
Elbow and Wrist Injuries
Hip Injuries
Other Injuries
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
KEY MARKET PLAYERS
Arthrex Inc.
CONMED Corporation,
DJO Global,
Johnson & Johnson
Mueller Sport Medicine
Orthofix International N.V
Smith & Nephew Plc.
Stryker Corporation
Wright Medical group
Zimmer Biomet Holdings ,Inc
- CHAPTER 1:INTRODUCTION
- 1.1.Report Description
- 1.2.Key Market Segments
- 1.3.Key Benefits
- 1.4.Research Methodology
- 1.4.1.Primary Research
- 1.4.2.Secondary Research
- 1.4.3.Analyst Tools and Models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.CXO Perspective
- CHAPTER 3:MARKET LANDSCAPE
- 3.1.Market Definition and Scope
- 3.2.Key Findings
- 3.2.1.Top Investment Pockets
- 3.2.2.Top Winning Strategies
- 3.3.Porter's Five Forces Analysis
- 3.3.1.Bargaining Power of Suppliers
- 3.3.2.Threat of New Entrants
- 3.3.3.Threat of Substitutes
- 3.3.4.Competitive Rivalry
- 3.3.5.Bargaining Power among Buyers
- 3.4.Market Share Analysis/Top Player Positioning
- 3.4.1.Market Share Analysis/Top Player Positioning 2020
- 3.5.Market Dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis
- CHAPTER 4:SPORTS MEDICINE MARKET, BY PRODUCT
- 4.1.Market Overview
- 4.1.1Market Size and Forecast, By Product
- 4.2.Body Reconstruction And Repair
- 4.2.1.Key Market Trends, Growth Factors and Opportunities
- 4.2.2.Market Size and Forecast, By Region
- 4.2.3.Market Share Analysis, By Country
- 4.3.Body Support And Recovery
- 4.3.1.Key Market Trends, Growth Factors and Opportunities
- 4.3.2.Market Size and Forecast, By Region
- 4.3.3.Market Share Analysis, By Country
- 4.4.Body Monitoring And Evaluation
- 4.4.1.Key Market Trends, Growth Factors and Opportunities
- 4.4.2.Market Size and Forecast, By Region
- 4.4.3.Market Share Analysis, By Country
- 4.5.Accessories
- 4.5.1.Key Market Trends, Growth Factors and Opportunities
- 4.5.2.Market Size and Forecast, By Region
- 4.5.3.Market Share Analysis, By Country
- CHAPTER 5:SPORTS MEDICINE MARKET, BY APPLICATION
- 5.1.Market Overview
- 5.1.1Market Size and Forecast, By Application
- 5.2.Knee Injuries
- 5.2.1.Key Market Trends, Growth Factors and Opportunities
- 5.2.2.Market Size and Forecast, By Region
- 5.2.3.Market Share Analysis, By Country
- 5.3.Shoulder Injuries
- 5.3.1.Key Market Trends, Growth Factors and Opportunities
- 5.3.2.Market Size and Forecast, By Region
- 5.3.3.Market Share Analysis, By Country
- 5.4.Ankle And Foot Injuries
- 5.4.1.Key Market Trends, Growth Factors and Opportunities
- 5.4.2.Market Size and Forecast, By Region
- 5.4.3.Market Share Analysis, By Country
- 5.5.Back And Spine Injuries
- 5.5.1.Key Market Trends, Growth Factors and Opportunities
- 5.5.2.Market Size and Forecast, By Region
- 5.5.3.Market Share Analysis, By Country
- 5.6.Elbow And Wrist Injuries
- 5.6.1.Key Market Trends, Growth Factors and Opportunities
- 5.6.2.Market Size and Forecast, By Region
- 5.6.3.Market Share Analysis, By Country
- 5.7.Hip Injuries
- 5.7.1.Key Market Trends, Growth Factors and Opportunities
- 5.7.2.Market Size and Forecast, By Region
- 5.7.3.Market Share Analysis, By Country
- 5.8.Other Injuries
- 5.8.1.Key Market Trends, Growth Factors and Opportunities
- 5.8.2.Market Size and Forecast, By Region
- 5.8.3.Market Share Analysis, By Country
- CHAPTER 6:SPORTS MEDICINE MARKET, BY REGION
- 6.1.Market Overview
- 6.1.1Market Size and Forecast, By Regio
- 6.2.North America
- 6.2.1.Key Market Trends and Opportunities
- 6.2.2.Market Size and Forecast, By Product
- 6.2.3.Market Size and Forecast, By Application
- 6.2.4.Market Size and Forecast, By Country
- 6.2.5.United States Sports Medicine Market
- 6.2.5.1.Market Size and Forecast, By Product
- 6.2.5.2.Market Size and Forecast, By Application
- 6.2.6.Canada Sports Medicine Market
- 6.2.6.1.Market Size and Forecast, By Product
- 6.2.6.2.Market Size and Forecast, By Application
- 6.2.7.Mexico Sports Medicine Market
- 6.2.7.1.Market Size and Forecast, By Product
- 6.2.7.2.Market Size and Forecast, By Application
- 6.3.Europe
- 6.3.1.Key Market Trends and Opportunities
- 6.3.2.Market Size and Forecast, By Product
- 6.3.3.Market Size and Forecast, By Application
- 6.3.4.Market Size and Forecast, By Country
- 6.3.5.France Sports Medicine Market
- 6.3.5.1.Market Size and Forecast, By Product
- 6.3.5.2.Market Size and Forecast, By Application
- 6.3.6.Germany Sports Medicine Market
- 6.3.6.1.Market Size and Forecast, By Product
- 6.3.6.2.Market Size and Forecast, By Application
- 6.3.7.Uk Sports Medicine Market
- 6.3.7.1.Market Size and Forecast, By Product
- 6.3.7.2.Market Size and Forecast, By Application
- 6.3.8.Italy Sports Medicine Market
- 6.3.8.1.Market Size and Forecast, By Product
- 6.3.8.2.Market Size and Forecast, By Application
- 6.3.9.Spain Sports Medicine Market
- 6.3.9.1.Market Size and Forecast, By Product
- 6.3.9.2.Market Size and Forecast, By Application
- 6.3.10.Rest Of Europe Sports Medicine Market
- 6.3.10.1.Market Size and Forecast, By Product
- 6.3.10.2.Market Size and Forecast, By Application
- 6.4.Asia-Pacific
- 6.4.1.Key Market Trends and Opportunities
- 6.4.2.Market Size and Forecast, By Product
- 6.4.3.Market Size and Forecast, By Application
- 6.4.4.Market Size and Forecast, By Country
- 6.4.5.Japan Sports Medicine Market
- 6.4.5.1.Market Size and Forecast, By Product
- 6.4.5.2.Market Size and Forecast, By Application
- 6.4.6.China Sports Medicine Market
- 6.4.6.1.Market Size and Forecast, By Product
- 6.4.6.2.Market Size and Forecast, By Application
- 6.4.7.Australia Sports Medicine Market
- 6.4.7.1.Market Size and Forecast, By Product
- 6.4.7.2.Market Size and Forecast, By Application
- 6.4.8.India Sports Medicine Market
- 6.4.8.1.Market Size and Forecast, By Product
- 6.4.8.2.Market Size and Forecast, By Application
- 6.4.9.South Korea Sports Medicine Market
- 6.4.9.1.Market Size and Forecast, By Product
- 6.4.9.2.Market Size and Forecast, By Application
- 6.4.10.Rest Of Asia-pacific Sports Medicine Market
- 6.4.10.1.Market Size and Forecast, By Product
- 6.4.10.2.Market Size and Forecast, By Application
- 6.5.LAMEA
- 6.5.1.Key Market Trends and Opportunities
- 6.5.2.Market Size and Forecast, By Product
- 6.5.3.Market Size and Forecast, By Application
- 6.5.4.Market Size and Forecast, By Country
- 6.5.5.Brazil Sports Medicine Market
- 6.5.5.1.Market Size and Forecast, By Product
- 6.5.5.2.Market Size and Forecast, By Application
- 6.5.6.Saudi Arabia Sports Medicine Market
- 6.5.6.1.Market Size and Forecast, By Product
- 6.5.6.2.Market Size and Forecast, By Application
- 6.5.7.South Africa Sports Medicine Market
- 6.5.7.1.Market Size and Forecast, By Product
- 6.5.7.2.Market Size and Forecast, By Application
- 6.5.8.Rest of LAMEA Sports Medicine Market
- 6.5.8.1.Market Size and Forecast, By Product
- 6.5.8.2.Market Size and Forecast, By Application
- CHAPTER 7:COMPANY PROFILES
- 7.1.Arthrex, Inc
- 7.1.1.Company Overview
- 7.1.2.Key Executives
- 7.1.3.Company snapshot
- 7.1.4.Operating business segments
- 7.1.5.Product portfolio
- 7.1.6.Business Performance
- 7.1.7.Key Strategic Moves and Developments
- 7.2.CONMED
- 7.2.1.Company Overview
- 7.2.2.Key Executives
- 7.2.3.Company snapshot
- 7.2.4.Operating business segments
- 7.2.5.Product portfolio
- 7.2.6.Business Performance
- 7.2.7.Key Strategic Moves and Developments
- 7.3.DJO Global, Inc.
- 7.3.1.Company Overview
- 7.3.2.Key Executives
- 7.3.3.Company snapshot
- 7.3.4.Operating business segments
- 7.3.5.Product portfolio
- 7.3.6.Business Performance
- 7.3.7.Key Strategic Moves and Developments
- 7.4.Johnson And Johnson
- 7.4.1.Company Overview
- 7.4.2.Key Executives
- 7.4.3.Company snapshot
- 7.4.4.Operating business segments
- 7.4.5.Product portfolio
- 7.4.6.Business Performance
- 7.4.7.Key Strategic Moves and Developments
- 7.5.Mueller Sports Medicine
- 7.5.1.Company Overview
- 7.5.2.Key Executives
- 7.5.3.Company snapshot
- 7.5.4.Operating business segments
- 7.5.5.Product portfolio
- 7.5.6.Business Performance
- 7.5.7.Key Strategic Moves and Developments
- 7.6.Orthofix International N.V.
- 7.6.1.Company Overview
- 7.6.2.Key Executives
- 7.6.3.Company snapshot
- 7.6.4.Operating business segments
- 7.6.5.Product portfolio
- 7.6.6.Business Performance
- 7.6.7.Key Strategic Moves and Developments
- 7.7.Smith And Nephew Plc
- 7.7.1.Company Overview
- 7.7.2.Key Executives
- 7.7.3.Company snapshot
- 7.7.4.Operating business segments
- 7.7.5.Product portfolio
- 7.7.6.Business Performance
- 7.7.7.Key Strategic Moves and Developments
- 7.8.Stryker Corporation
- 7.8.1.Company Overview
- 7.8.2.Key Executives
- 7.8.3.Company snapshot
- 7.8.4.Operating business segments
- 7.8.5.Product portfolio
- 7.8.6.Business Performance
- 7.8.7.Key Strategic Moves and Developments
- 7.9.Wright Medical Group, Inc
- 7.9.1.Company Overview
- 7.9.2.Key Executives
- 7.9.3.Company snapshot
- 7.9.4.Operating business segments
- 7.9.5.Product portfolio
- 7.9.6.Business Performance
- 7.9.7.Key Strategic Moves and Developments
- 7.10.Zimmer Biomet Holdings, Inc.
- 7.10.1.Company Overview
- 7.10.2.Key Executives
- 7.10.3.Company snapshot
- 7.10.4.Operating business segments
- 7.10.5.Product portfolio
- 7.10.6.Business Performance
- 7.10.7.Key Strategic Moves and Developments
- LIST OF TABLES
- TABLE 1.GLOBAL SPORTS MEDICINE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 2.GLOBAL SPORTS MEDICINE MARKET FOR BODY RECONSTRUCTION AND REPAIR, BY REGION, 2020-2030 ($MILLION)
- TABLE 3.GLOBAL SPORTS MEDICINE MARKET FOR BODY SUPPORT AND RECOVERY, BY REGION, 2020-2030 ($MILLION)
- TABLE 4.GLOBAL SPORTS MEDICINE MARKET FOR BODY MONITORING AND EVALUATION, BY REGION, 2020-2030 ($MILLION)
- TABLE 5.GLOBAL SPORTS MEDICINE MARKET FOR ACCESSORIES, BY REGION, 2020-2030 ($MILLION)
- TABLE 6.GLOBAL SPORTS MEDICINE MARKET, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 7.GLOBAL SPORTS MEDICINE MARKET FOR KNEE INJURIES, BY REGION, 2020-2030 ($MILLION)
- TABLE 8.GLOBAL SPORTS MEDICINE MARKET FOR SHOULDER INJURIES, BY REGION, 2020-2030 ($MILLION)
- TABLE 9.GLOBAL SPORTS MEDICINE MARKET FOR ANKLE AND FOOT INJURIES, BY REGION, 2020-2030 ($MILLION)
- TABLE 10.GLOBAL SPORTS MEDICINE MARKET FOR BACK AND SPINE INJURIES, BY REGION, 2020-2030 ($MILLION)
- TABLE 11.GLOBAL SPORTS MEDICINE MARKET FOR ELBOW AND WRIST INJURIES, BY REGION, 2020-2030 ($MILLION)
- TABLE 12.GLOBAL SPORTS MEDICINE MARKET FOR HIP INJURIES, BY REGION, 2020-2030 ($MILLION)
- TABLE 13.GLOBAL SPORTS MEDICINE MARKET FOR OTHER INJURIES, BY REGION, 2020-2030 ($MILLION)
- TABLE 14.GLOBAL SPORTS MEDICINE MARKET, BY REGION, 2020-2030 ($MILLION)
- TABLE 15.NORTH AMERICA SPORTS MEDICINE, BY Region, 2020-2030 ($MILLION)
- TABLE 16.NORTH AMERICA SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 17.NORTH AMERICA SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 18.UNITED STATES SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 19.UNITED STATES SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 20.CANADA SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 21.CANADA SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 22.MEXICO SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 23.MEXICO SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 24.EUROPE SPORTS MEDICINE, BY Region, 2020-2030 ($MILLION)
- TABLE 25.EUROPE SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 26.EUROPE SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 27.FRANCE SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 28.FRANCE SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 29.GERMANY SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 30.GERMANY SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 31.UK SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 32.UK SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 33.ITALY SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 34.ITALY SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 35.SPAIN SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 36.SPAIN SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 37.REST OF EUROPE SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 38.REST OF EUROPE SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 39.ASIA-PACIFIC SPORTS MEDICINE, BY Region, 2020-2030 ($MILLION)
- TABLE 40.ASIA-PACIFIC SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 41.ASIA-PACIFIC SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 42.JAPAN SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 43.JAPAN SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 44.CHINA SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 45.CHINA SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 46.AUSTRALIA SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 47.AUSTRALIA SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 48.INDIA SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 49.INDIA SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 50.SOUTH KOREA SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 51.SOUTH KOREA SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 52.REST OF ASIA-PACIFIC SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 53.REST OF ASIA-PACIFIC SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 54.LAMEA SPORTS MEDICINE, BY Region, 2020-2030 ($MILLION)
- TABLE 55.LAMEA SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 56.LAMEA SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 57.BRAZIL SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 58.BRAZIL SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 59.SAUDI ARABIA SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 60.SAUDI ARABIA SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 61.SOUTH AFRICA SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 62.SOUTH AFRICA SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 63.REST OF LAMEA SPORTS MEDICINE, BY PRODUCT, 2020-2030 ($MILLION)
- TABLE 64.REST OF LAMEA SPORTS MEDICINE, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 65.ARTHREX, INC: KEY EXECUTIVES
- TABLE 66.ARTHREX, INC: COMPANY SNAPSHOT
- TABLE 67.ARTHREX, INC: OPERATING SEGMENTS
- TABLE 68.ARTHREX, INC: PRODUCT PORTFOLIO
- TABLE 69.ARTHREX, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 70.CONMED: KEY EXECUTIVES
- TABLE 71.CONMED: COMPANY SNAPSHOT
- TABLE 72.CONMED: OPERATING SEGMENTS
- TABLE 73.CONMED: PRODUCT PORTFOLIO
- TABLE 74.CONMED: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 75.DJO GLOBAL, INC.: KEY EXECUTIVES
- TABLE 76.DJO GLOBAL, INC.: COMPANY SNAPSHOT
- TABLE 77.DJO GLOBAL, INC.: OPERATING SEGMENTS
- TABLE 78.DJO GLOBAL, INC.: PRODUCT PORTFOLIO
- TABLE 79.DJO GLOBAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 80.JOHNSON AND JOHNSON: KEY EXECUTIVES
- TABLE 81.JOHNSON AND JOHNSON: COMPANY SNAPSHOT
- TABLE 82.JOHNSON AND JOHNSON: OPERATING SEGMENTS
- TABLE 83.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
- TABLE 84.JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 85.MUELLER SPORTS MEDICINE: KEY EXECUTIVES
- TABLE 86.MUELLER SPORTS MEDICINE: COMPANY SNAPSHOT
- TABLE 87.MUELLER SPORTS MEDICINE: OPERATING SEGMENTS
- TABLE 88.MUELLER SPORTS MEDICINE: PRODUCT PORTFOLIO
- TABLE 89.MUELLER SPORTS MEDICINE: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 90.ORTHOFIX INTERNATIONAL N.V.: KEY EXECUTIVES
- TABLE 91.ORTHOFIX INTERNATIONAL N.V.: COMPANY SNAPSHOT
- TABLE 92.ORTHOFIX INTERNATIONAL N.V.: OPERATING SEGMENTS
- TABLE 93.ORTHOFIX INTERNATIONAL N.V.: PRODUCT PORTFOLIO
- TABLE 94.ORTHOFIX INTERNATIONAL N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 95.SMITH AND NEPHEW PLC: KEY EXECUTIVES
- TABLE 96.SMITH AND NEPHEW PLC: COMPANY SNAPSHOT
- TABLE 97.SMITH AND NEPHEW PLC: OPERATING SEGMENTS
- TABLE 98.SMITH AND NEPHEW PLC: PRODUCT PORTFOLIO
- TABLE 99.SMITH AND NEPHEW PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 100.STRYKER CORPORATION: KEY EXECUTIVES
- TABLE 101.STRYKER CORPORATION: COMPANY SNAPSHOT
- TABLE 102.STRYKER CORPORATION: OPERATING SEGMENTS
- TABLE 103.STRYKER CORPORATION: PRODUCT PORTFOLIO
- TABLE 104.STRYKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 105.WRIGHT MEDICAL GROUP, INC: KEY EXECUTIVES
- TABLE 106.WRIGHT MEDICAL GROUP, INC: COMPANY SNAPSHOT
- TABLE 107.WRIGHT MEDICAL GROUP, INC: OPERATING SEGMENTS
- TABLE 108.WRIGHT MEDICAL GROUP, INC: PRODUCT PORTFOLIO
- TABLE 109.WRIGHT MEDICAL GROUP, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 110.ZIMMER BIOMET HOLDINGS, INC.: KEY EXECUTIVES
- TABLE 111.ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT
- TABLE 112.ZIMMER BIOMET HOLDINGS, INC.: OPERATING SEGMENTS
- TABLE 113.ZIMMER BIOMET HOLDINGS, INC.: PRODUCT PORTFOLIO
- TABLE 114.ZIMMER BIOMET HOLDINGS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1.GLOBAL SPORTS MEDICINE MARKET SEGMENTATION
- FIGURE 2.GLOBAL SPORTS MEDICINE MARKET
- FIGURE 3.SEGMENTATION SPORTS MEDICINE MARKET
- FIGURE 4.TOP INVESTMENT POCKET IN SPORTS MEDICINE MARKET
- FIGURE 5.TOP WINNING STRATEGIES, 2019-2021*
- FIGURE 6.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021(%)
- FIGURE 7.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
- FIGURE 8.MODERATE BARGAINING POWER OF BUYERS
- FIGURE 9.MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 10.MODERATE THREAT OF NEW ENTRANTS
- FIGURE 11.LOW THREAT OF SUBSTITUTION
- FIGURE 12.HIGH COMPETITIVE RIVALRY
- FIGURE 13.TOP PLAYER POSITIONING, 2020
- FIGURE 14.MARKET SHARE ANALYSIS, 2020
- FIGURE 15.RESTRAINTS AND DRIVERS: SPORTS MEDICINE MARKET
- FIGURE 16.SPORTS MEDICINE MARKET SEGMENTATION, BY PRODUCT
- FIGURE 17.SPORTS MEDICINE MARKET FOR BODY RECONSTRUCTION AND REPAIR, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 18.SPORTS MEDICINE MARKET FOR BODY SUPPORT AND RECOVERY, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 19.SPORTS MEDICINE MARKET FOR BODY MONITORING AND EVALUATION, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 20.SPORTS MEDICINE MARKET FOR ACCESSORIES, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 21.SPORTS MEDICINE MARKET SEGMENTATION, BY APPLICATION
- FIGURE 22.SPORTS MEDICINE MARKET FOR KNEE INJURIES, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 23.SPORTS MEDICINE MARKET FOR SHOULDER INJURIES, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 24.SPORTS MEDICINE MARKET FOR ANKLE AND FOOT INJURIES, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 25.SPORTS MEDICINE MARKET FOR BACK AND SPINE INJURIES, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 26.SPORTS MEDICINE MARKET FOR ELBOW AND WRIST INJURIES, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 27.SPORTS MEDICINE MARKET FOR HIP INJURIES, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 28.SPORTS MEDICINE MARKET FOR OTHER INJURIES, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 29.ARTHREX, INC: NET SALES, 2018-2020 ($MILLION)
- FIGURE 30.ARTHREX, INC: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 31.ARTHREX, INC: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 32.CONMED: NET SALES, 2018-2020 ($MILLION)
- FIGURE 33.CONMED: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 34.CONMED: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 35.DJO GLOBAL, INC.: NET SALES, 2018-2020 ($MILLION)
- FIGURE 36.DJO GLOBAL, INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 37.DJO GLOBAL, INC.: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 38.JOHNSON AND JOHNSON: NET SALES, 2018-2020 ($MILLION)
- FIGURE 39.JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 40.JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 41.MUELLER SPORTS MEDICINE: NET SALES, 2018-2020 ($MILLION)
- FIGURE 42.MUELLER SPORTS MEDICINE: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 43.MUELLER SPORTS MEDICINE: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 44.ORTHOFIX INTERNATIONAL N.V.: NET SALES, 2018-2020 ($MILLION)
- FIGURE 45.ORTHOFIX INTERNATIONAL N.V.: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 46.ORTHOFIX INTERNATIONAL N.V.: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 47.SMITH AND NEPHEW PLC: NET SALES, 2018-2020 ($MILLION)
- FIGURE 48.SMITH AND NEPHEW PLC: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 49.SMITH AND NEPHEW PLC: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 50.STRYKER CORPORATION: NET SALES, 2018-2020 ($MILLION)
- FIGURE 51.STRYKER CORPORATION: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 52.STRYKER CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 53.WRIGHT MEDICAL GROUP, INC: NET SALES, 2018-2020 ($MILLION)
- FIGURE 54.WRIGHT MEDICAL GROUP, INC: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 55.WRIGHT MEDICAL GROUP, INC: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 56.ZIMMER BIOMET HOLDINGS, INC.: NET SALES, 2018-2020 ($MILLION)
- FIGURE 57.ZIMMER BIOMET HOLDINGS, INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 58.ZIMMER BIOMET HOLDINGS, INC.: REVENUE SHARE, BY REGION, 2020 (%)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook